FDA.reportPublic FDA data

rivaroxaban 1 MG/ML Oral Suspension

RxCUI
2588062
RxNorm name
rivaroxaban 1 MG/ML Oral Suspension
Display name
rivaroxaban 1 MG/ML Oral Suspension
Full name
rivaroxaban 1 MG/ML Oral Suspension
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
rivaroxaban granuleRIVAROXABAN GRANULELupin Pharmaceuticals, Inc.b0306b06-d8cf-48de-9e93-57d77e4e98f52026-04-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2588062
XareltoRIVAROXABANJanssen Pharmaceuticals, Inc.10db92f9-2300-4a80-836b-673e1ae916102026-01-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2588062
RivaroxabanRIVAROXABANAscend Laboratories, LLCc0efa9f9-ca7a-471a-8030-99056fa5da092025-07-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2588062

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
10db92f9-2300-4a80-836b-673e1ae91610rivaroxaban 1 MG/mL Oral SuspensionPSN64These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 201120260116
10db92f9-2300-4a80-836b-673e1ae91610rivaroxaban 1 MG/ML Oral SuspensionSCD64These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 201120260116
b0306b06-d8cf-48de-9e93-57d77e4e98f5rivaroxaban 1 MG/ML Oral SuspensionSCD7These highlights do not include all the information needed to use RIVAROXABAN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for RIVAROXABAN FOR ORAL SUSPENSION. RIVAROXABAN for oral suspension Initial U.S. Approval: 201120260413
b0306b06-d8cf-48de-9e93-57d77e4e98f5rivaroxaban 1 MG/mL Oral SuspensionPSN7These highlights do not include all the information needed to use RIVAROXABAN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for RIVAROXABAN FOR ORAL SUSPENSION. RIVAROXABAN for oral suspension Initial U.S. Approval: 201120260413
c0efa9f9-ca7a-471a-8030-99056fa5da09rivaroxaban 1 MG/mL Oral SuspensionPSN5These highlights do not include all the information needed to use RIVAROXABAN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for RIVAROXABAN FOR ORAL SUSPENSION. RIVAROXABAN for oral suspension Initial U.S. Approval: 201120250701
c0efa9f9-ca7a-471a-8030-99056fa5da09rivaroxaban 1 MG/ML Oral SuspensionSCD5These highlights do not include all the information needed to use RIVAROXABAN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for RIVAROXABAN FOR ORAL SUSPENSION. RIVAROXABAN for oral suspension Initial U.S. Approval: 201120250701